Daniel A Hamstra
Overview
Explore the profile of Daniel A Hamstra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
2498
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Folkert M, Sato R, Yu J, Vannan D, Bhattacharyya S, Noriega C, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250491.
PMID: 40067300
Importance: The polyethylene glycol-based hydrogel spacer (PHS) system temporarily separates the rectum from the prostate in patients undergoing radiotherapy (RT) for prostate cancer (PCa). Objective: To compare incidence of bowel...
2.
Patel S, Patil D, Smith J, Saigal C, Litwin M, Hu J, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2440747.
PMID: 39446326
Importance: The association between radiotherapy (RT) timing after radical prostatectomy and long-term patient-reported health-related quality of life (HRQOL) in men with prostate cancer is unknown. Objective: To measure long-term HRQOL...
3.
Dong E, Xu J, Kim J, Bryan J, Appleton J, Hamstra D, et al.
Radiat Oncol
. 2024 Mar;
19(1):35.
PMID: 38481285
Background: Diffusion-weighted magnetic resonance imaging (DWI) provides a measurement of tumor cellularity. We evaluated the potential of apparent diffusion coefficient (ADC) values obtained from post-external beam radiation therapy (EBRT) DWI...
4.
Seymour Z, Pinkawa M, Daignault-Newton S, Bosch W, Michalski J, Gay H, et al.
Front Oncol
. 2023 Oct;
13:1239104.
PMID: 37886176
Purpose: The purpose of this study was to analyze the impact of prostate rectal spacers on sexual quality of life (QOL) following external beam radiation therapy (RT). Methods And Materials:...
5.
Sapienza L, Thomas J, Echeverria A, Sharma S, Hamstra D, Hall T, et al.
Gynecol Oncol Rep
. 2022 Nov;
44:101091.
PMID: 36325116
Introduction: Non-compliance to post-treatment cancer surveillance can lead to late detection of recurrence. This study aims to identify patients at high risk for loss of follow-up after radiotherapy for locally...
6.
Jafferji M, Hamstra D, Groth S
Ann Thorac Surg
. 2022 Sep;
115(2):354-355.
PMID: 36070808
No abstract available.
7.
Seymour Z, Daignault-Newton S, McLaughlin P, Sandler H, Jackson W, Johnson S, et al.
Clin Transl Radiat Oncol
. 2022 Jul;
36:56-62.
PMID: 35813938
Objective/purpose: Previously patient reported quality of life (QOL) was reported in men with prostate cancer a mean 2 and 6 years post treatment with open radical prostatectomy (RP), 3D conformal...
8.
Rao A, Moka N, Hamstra D, Ryan C
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35159068
Metastatic prostate cancer remains lethal with a 5-year survival rate of about 30%, indicating the need for better treatment options. Novel antiandrogens (NAA)-enzalutamide and abiraterone-have been the mainstay of treatment...
9.
Parzen J, Hamstra D
Int J Radiat Oncol Biol Phys
. 2021 Jun;
110(4):1129-1131.
PMID: 34171237
No abstract available.
10.
Thompson A, Hamstra D
Int J Radiat Oncol Biol Phys
. 2020 Sep;
108(3):644-648.
PMID: 32976788
No abstract available.